Journal for ImmunoTherapy of Cancer-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1065742, encodeId=9dda1065e429f, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2600.0 偏重的研究方向：肿瘤免疫 经验分享：投稿两周，转态由 Awaiting reviewer selection 到Awaiting reviewer assignment 一周，10天左右变成Awaiting Recommendation，这是送外审还是没送哇，，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0985683001, createdName=ms3000001376117297, createdTime=Mon Nov 01 11:12:57 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885694, encodeId=bda8885694d0, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2600.0 偏重的研究方向：肿瘤学;免疫学 经验分享：2019.12.11投稿 2020.2.19 一审大修（但审稿人意见很好） ddl 2020.4.30 因为疫情申请延期至2020.8.30 2020.7.30 提交修改 2020.8.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/f1f34ee4cda0400b868a6737dc7d94ce/218a47331c3d4dfa87d5eed663b32c78.png, createdBy=c9df2167769, createdName=Andrew112358, createdTime=Wed Sep 16 09:25:28 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588482, encodeId=4c7e58848271, content=请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？176****8117暂无昵称 2020-02-24 00:00:00 发表: 去年7月25投稿，9月27日一审大修两个月时间，3个审稿人。11月20修回，二审两个月，今年1月20返回意见让修改一个图注问题。2月12号正式接收。, beContent=176****8117暂无昵称 2020-02-24 00:00:00 发表: 去年7月25投稿，9月27日一审大修两个月时间，3个审稿人。11月20修回，二审两个月，今年1月20返回意见让修改一个图注问题。2月12号正式接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160126/IMG56A79212C4AA18639.jpg, createdBy=fadd1683002, createdName=shaobom.shca, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911223, encodeId=111b91122357, content=现在状态是awaiting decision，是凉的意思吗？还是说内审决定送不送外审都会有这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48aa5286894, createdName=148555c3m25(暂无昵称), createdTime=Sun Dec 27 11:54:15 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115003, encodeId=5112211500396, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤免疫 经验分享：目前很困难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=DDPP, createdTime=Fri Feb 17 00:06:36 CST 2023, time=2023-02-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=586482, encodeId=66b658648216, content=Awaiting section editor handling-Awaiting reviewer selection-Awaiting reviewer assigned-Awaiting recommendation-Awaiting decision-reject，历经一周时间，这是内审没过，那送外审是什么状态呢？这里的reviewer 一直指的是editor，这样很容易误导作者以为送外审了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJFrt3WdV0nESgrJiaELZI7Xj0uNOFjt052Thc8Aomg4thuSWnkyzaZYqIJhPLkIgWaIbswDxUW2sg/132, createdBy=608d1996208, createdName=西西131401, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226934, encodeId=54b812269342d, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：临床肿瘤免疫 经验分享：2022元旦投稿 2022年3月中旬一审结果，大修，两个reviewer和editor都感兴趣，但也提了很多很多问题 2022年5月中旬修回期限最后一个小时提交一审修回 2022年6月1号二审结果，小修，两个reviewer对response很满意，reviewer 1追加了2个小问题 2022-6-10二审修回 2022-6-18 Accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2HQN0tx7bEeQhg1dSQGicdJL7tOD7icU2u5HHfxxM4Gea1zc6m7bNniaS2zETp3dS2P6cAr9Ca5Q2debcyjum1fjQ/132, createdBy=5b491679614, createdName=石头3, createdTime=Fri Jun 17 00:02:33 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971736, encodeId=64ab9e17367e, content=非常慢，而且感觉杂志很不负责任。快两个月了，状态一直都是“Awaiting Reviewer Selection”，发了两次邮件去询问，也没有回复的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4f931674603, createdName=hhhhhhq, createdTime=Tue Jun 08 09:36:33 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970704, encodeId=184d9e070419, content=审稿速度:6.0 | 投稿命中率:25.0 | 审稿费用:2500.0 偏重的研究方向：机制 经验分享：很墨迹的一个杂志，投了稿子就石沉大海，性价比不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8be71979633, createdName=laowan, createdTime=Thu Jun 03 22:40:44 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142895, encodeId=efe42142895b8, content=为什么一直保持10分以上，还是中科院二区，还不如BMC medicine吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=18525506506, createdName=ms4000001058776765, createdTime=Thu Jun 15 09:34:20 CST 2023, time=2023-06-15, status=1, ipAttribution=北京)]

2021-11-01 ms3000001376117297

审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2600.0
偏重的研究方向：肿瘤免疫
经验分享：投稿两周，转态由 Awaiting reviewer selection 到Awaiting reviewer assignment 一周，10天左右变成Awaiting Recommendation，这是送外审还是没送哇，，，，

96 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1065742, encodeId=9dda1065e429f, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2600.0 偏重的研究方向：肿瘤免疫 经验分享：投稿两周，转态由 Awaiting reviewer selection 到Awaiting reviewer assignment 一周，10天左右变成Awaiting Recommendation，这是送外审还是没送哇，，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0985683001, createdName=ms3000001376117297, createdTime=Mon Nov 01 11:12:57 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885694, encodeId=bda8885694d0, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2600.0 偏重的研究方向：肿瘤学;免疫学 经验分享：2019.12.11投稿 2020.2.19 一审大修（但审稿人意见很好） ddl 2020.4.30 因为疫情申请延期至2020.8.30 2020.7.30 提交修改 2020.8.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/f1f34ee4cda0400b868a6737dc7d94ce/218a47331c3d4dfa87d5eed663b32c78.png, createdBy=c9df2167769, createdName=Andrew112358, createdTime=Wed Sep 16 09:25:28 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588482, encodeId=4c7e58848271, content=请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？176****8117暂无昵称 2020-02-24 00:00:00 发表: 去年7月25投稿，9月27日一审大修两个月时间，3个审稿人。11月20修回，二审两个月，今年1月20返回意见让修改一个图注问题。2月12号正式接收。, beContent=176****8117暂无昵称 2020-02-24 00:00:00 发表: 去年7月25投稿，9月27日一审大修两个月时间，3个审稿人。11月20修回，二审两个月，今年1月20返回意见让修改一个图注问题。2月12号正式接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160126/IMG56A79212C4AA18639.jpg, createdBy=fadd1683002, createdName=shaobom.shca, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911223, encodeId=111b91122357, content=现在状态是awaiting decision，是凉的意思吗？还是说内审决定送不送外审都会有这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48aa5286894, createdName=148555c3m25(暂无昵称), createdTime=Sun Dec 27 11:54:15 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115003, encodeId=5112211500396, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤免疫 经验分享：目前很困难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=DDPP, createdTime=Fri Feb 17 00:06:36 CST 2023, time=2023-02-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=586482, encodeId=66b658648216, content=Awaiting section editor handling-Awaiting reviewer selection-Awaiting reviewer assigned-Awaiting recommendation-Awaiting decision-reject，历经一周时间，这是内审没过，那送外审是什么状态呢？这里的reviewer 一直指的是editor，这样很容易误导作者以为送外审了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJFrt3WdV0nESgrJiaELZI7Xj0uNOFjt052Thc8Aomg4thuSWnkyzaZYqIJhPLkIgWaIbswDxUW2sg/132, createdBy=608d1996208, createdName=西西131401, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226934, encodeId=54b812269342d, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：临床肿瘤免疫 经验分享：2022元旦投稿 2022年3月中旬一审结果，大修，两个reviewer和editor都感兴趣，但也提了很多很多问题 2022年5月中旬修回期限最后一个小时提交一审修回 2022年6月1号二审结果，小修，两个reviewer对response很满意，reviewer 1追加了2个小问题 2022-6-10二审修回 2022-6-18 Accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2HQN0tx7bEeQhg1dSQGicdJL7tOD7icU2u5HHfxxM4Gea1zc6m7bNniaS2zETp3dS2P6cAr9Ca5Q2debcyjum1fjQ/132, createdBy=5b491679614, createdName=石头3, createdTime=Fri Jun 17 00:02:33 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971736, encodeId=64ab9e17367e, content=非常慢，而且感觉杂志很不负责任。快两个月了，状态一直都是“Awaiting Reviewer Selection”，发了两次邮件去询问，也没有回复的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4f931674603, createdName=hhhhhhq, createdTime=Tue Jun 08 09:36:33 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970704, encodeId=184d9e070419, content=审稿速度:6.0 | 投稿命中率:25.0 | 审稿费用:2500.0 偏重的研究方向：机制 经验分享：很墨迹的一个杂志，投了稿子就石沉大海，性价比不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8be71979633, createdName=laowan, createdTime=Thu Jun 03 22:40:44 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142895, encodeId=efe42142895b8, content=为什么一直保持10分以上，还是中科院二区，还不如BMC medicine吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=18525506506, createdName=ms4000001058776765, createdTime=Thu Jun 15 09:34:20 CST 2023, time=2023-06-15, status=1, ipAttribution=北京)]

2020-09-16 Andrew112358

审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2600.0
偏重的研究方向：肿瘤学;免疫学
经验分享：2019.12.11投稿
2020.2.19 一审大修（但审稿人意见很好） ddl 2020.4.30
因为疫情申请延期至2020.8.30
2020.7.30 提交修改
2020.8.23 接收

154 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1065742, encodeId=9dda1065e429f, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2600.0 偏重的研究方向：肿瘤免疫 经验分享：投稿两周，转态由 Awaiting reviewer selection 到Awaiting reviewer assignment 一周，10天左右变成Awaiting Recommendation，这是送外审还是没送哇，，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0985683001, createdName=ms3000001376117297, createdTime=Mon Nov 01 11:12:57 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885694, encodeId=bda8885694d0, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2600.0 偏重的研究方向：肿瘤学;免疫学 经验分享：2019.12.11投稿 2020.2.19 一审大修（但审稿人意见很好） ddl 2020.4.30 因为疫情申请延期至2020.8.30 2020.7.30 提交修改 2020.8.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/f1f34ee4cda0400b868a6737dc7d94ce/218a47331c3d4dfa87d5eed663b32c78.png, createdBy=c9df2167769, createdName=Andrew112358, createdTime=Wed Sep 16 09:25:28 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588482, encodeId=4c7e58848271, content=请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？176****8117暂无昵称 2020-02-24 00:00:00 发表: 去年7月25投稿，9月27日一审大修两个月时间，3个审稿人。11月20修回，二审两个月，今年1月20返回意见让修改一个图注问题。2月12号正式接收。, beContent=176****8117暂无昵称 2020-02-24 00:00:00 发表: 去年7月25投稿，9月27日一审大修两个月时间，3个审稿人。11月20修回，二审两个月，今年1月20返回意见让修改一个图注问题。2月12号正式接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160126/IMG56A79212C4AA18639.jpg, createdBy=fadd1683002, createdName=shaobom.shca, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911223, encodeId=111b91122357, content=现在状态是awaiting decision，是凉的意思吗？还是说内审决定送不送外审都会有这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48aa5286894, createdName=148555c3m25(暂无昵称), createdTime=Sun Dec 27 11:54:15 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115003, encodeId=5112211500396, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤免疫 经验分享：目前很困难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=DDPP, createdTime=Fri Feb 17 00:06:36 CST 2023, time=2023-02-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=586482, encodeId=66b658648216, content=Awaiting section editor handling-Awaiting reviewer selection-Awaiting reviewer assigned-Awaiting recommendation-Awaiting decision-reject，历经一周时间，这是内审没过，那送外审是什么状态呢？这里的reviewer 一直指的是editor，这样很容易误导作者以为送外审了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJFrt3WdV0nESgrJiaELZI7Xj0uNOFjt052Thc8Aomg4thuSWnkyzaZYqIJhPLkIgWaIbswDxUW2sg/132, createdBy=608d1996208, createdName=西西131401, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226934, encodeId=54b812269342d, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：临床肿瘤免疫 经验分享：2022元旦投稿 2022年3月中旬一审结果，大修，两个reviewer和editor都感兴趣，但也提了很多很多问题 2022年5月中旬修回期限最后一个小时提交一审修回 2022年6月1号二审结果，小修，两个reviewer对response很满意，reviewer 1追加了2个小问题 2022-6-10二审修回 2022-6-18 Accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2HQN0tx7bEeQhg1dSQGicdJL7tOD7icU2u5HHfxxM4Gea1zc6m7bNniaS2zETp3dS2P6cAr9Ca5Q2debcyjum1fjQ/132, createdBy=5b491679614, createdName=石头3, createdTime=Fri Jun 17 00:02:33 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971736, encodeId=64ab9e17367e, content=非常慢，而且感觉杂志很不负责任。快两个月了，状态一直都是“Awaiting Reviewer Selection”，发了两次邮件去询问，也没有回复的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4f931674603, createdName=hhhhhhq, createdTime=Tue Jun 08 09:36:33 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970704, encodeId=184d9e070419, content=审稿速度:6.0 | 投稿命中率:25.0 | 审稿费用:2500.0 偏重的研究方向：机制 经验分享：很墨迹的一个杂志，投了稿子就石沉大海，性价比不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8be71979633, createdName=laowan, createdTime=Thu Jun 03 22:40:44 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142895, encodeId=efe42142895b8, content=为什么一直保持10分以上，还是中科院二区，还不如BMC medicine吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=18525506506, createdName=ms4000001058776765, createdTime=Thu Jun 15 09:34:20 CST 2023, time=2023-06-15, status=1, ipAttribution=北京)]

2020-04-09 shaobom.shca

请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？176****8117暂无昵称 2020-02-24 00:00:00 发表:
去年7月25投稿，9月27日一审大修两个月时间，3个审稿人。11月20修回，二审两个月，今年1月20返回意见让修改一个图注问题。2月12号正式接收。

176****8117暂无昵称 2020-02-24 00:00:00 发表: 去年7月25投稿，9月27日一审大修两个月时间，3个审稿人。11月20修回，二审两个月，今年1月20返回意见让修改一个图注问题。2月12号正式接收。

144 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1065742, encodeId=9dda1065e429f, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2600.0 偏重的研究方向：肿瘤免疫 经验分享：投稿两周，转态由 Awaiting reviewer selection 到Awaiting reviewer assignment 一周，10天左右变成Awaiting Recommendation，这是送外审还是没送哇，，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0985683001, createdName=ms3000001376117297, createdTime=Mon Nov 01 11:12:57 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885694, encodeId=bda8885694d0, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2600.0 偏重的研究方向：肿瘤学;免疫学 经验分享：2019.12.11投稿 2020.2.19 一审大修（但审稿人意见很好） ddl 2020.4.30 因为疫情申请延期至2020.8.30 2020.7.30 提交修改 2020.8.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/f1f34ee4cda0400b868a6737dc7d94ce/218a47331c3d4dfa87d5eed663b32c78.png, createdBy=c9df2167769, createdName=Andrew112358, createdTime=Wed Sep 16 09:25:28 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588482, encodeId=4c7e58848271, content=请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？176****8117暂无昵称 2020-02-24 00:00:00 发表: 去年7月25投稿，9月27日一审大修两个月时间，3个审稿人。11月20修回，二审两个月，今年1月20返回意见让修改一个图注问题。2月12号正式接收。, beContent=176****8117暂无昵称 2020-02-24 00:00:00 发表: 去年7月25投稿，9月27日一审大修两个月时间，3个审稿人。11月20修回，二审两个月，今年1月20返回意见让修改一个图注问题。2月12号正式接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160126/IMG56A79212C4AA18639.jpg, createdBy=fadd1683002, createdName=shaobom.shca, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911223, encodeId=111b91122357, content=现在状态是awaiting decision，是凉的意思吗？还是说内审决定送不送外审都会有这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48aa5286894, createdName=148555c3m25(暂无昵称), createdTime=Sun Dec 27 11:54:15 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115003, encodeId=5112211500396, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤免疫 经验分享：目前很困难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=DDPP, createdTime=Fri Feb 17 00:06:36 CST 2023, time=2023-02-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=586482, encodeId=66b658648216, content=Awaiting section editor handling-Awaiting reviewer selection-Awaiting reviewer assigned-Awaiting recommendation-Awaiting decision-reject，历经一周时间，这是内审没过，那送外审是什么状态呢？这里的reviewer 一直指的是editor，这样很容易误导作者以为送外审了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJFrt3WdV0nESgrJiaELZI7Xj0uNOFjt052Thc8Aomg4thuSWnkyzaZYqIJhPLkIgWaIbswDxUW2sg/132, createdBy=608d1996208, createdName=西西131401, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226934, encodeId=54b812269342d, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：临床肿瘤免疫 经验分享：2022元旦投稿 2022年3月中旬一审结果，大修，两个reviewer和editor都感兴趣，但也提了很多很多问题 2022年5月中旬修回期限最后一个小时提交一审修回 2022年6月1号二审结果，小修，两个reviewer对response很满意，reviewer 1追加了2个小问题 2022-6-10二审修回 2022-6-18 Accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2HQN0tx7bEeQhg1dSQGicdJL7tOD7icU2u5HHfxxM4Gea1zc6m7bNniaS2zETp3dS2P6cAr9Ca5Q2debcyjum1fjQ/132, createdBy=5b491679614, createdName=石头3, createdTime=Fri Jun 17 00:02:33 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971736, encodeId=64ab9e17367e, content=非常慢，而且感觉杂志很不负责任。快两个月了，状态一直都是“Awaiting Reviewer Selection”，发了两次邮件去询问，也没有回复的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4f931674603, createdName=hhhhhhq, createdTime=Tue Jun 08 09:36:33 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970704, encodeId=184d9e070419, content=审稿速度:6.0 | 投稿命中率:25.0 | 审稿费用:2500.0 偏重的研究方向：机制 经验分享：很墨迹的一个杂志，投了稿子就石沉大海，性价比不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8be71979633, createdName=laowan, createdTime=Thu Jun 03 22:40:44 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142895, encodeId=efe42142895b8, content=为什么一直保持10分以上，还是中科院二区，还不如BMC medicine吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=18525506506, createdName=ms4000001058776765, createdTime=Thu Jun 15 09:34:20 CST 2023, time=2023-06-15, status=1, ipAttribution=北京)]

2020-12-27 148555c3m25(暂无昵称)

现在状态是awaiting decision，是凉的意思吗？还是说内审决定送不送外审都会有这个状态

155 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1065742, encodeId=9dda1065e429f, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2600.0 偏重的研究方向：肿瘤免疫 经验分享：投稿两周，转态由 Awaiting reviewer selection 到Awaiting reviewer assignment 一周，10天左右变成Awaiting Recommendation，这是送外审还是没送哇，，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0985683001, createdName=ms3000001376117297, createdTime=Mon Nov 01 11:12:57 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885694, encodeId=bda8885694d0, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2600.0 偏重的研究方向：肿瘤学;免疫学 经验分享：2019.12.11投稿 2020.2.19 一审大修（但审稿人意见很好） ddl 2020.4.30 因为疫情申请延期至2020.8.30 2020.7.30 提交修改 2020.8.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/f1f34ee4cda0400b868a6737dc7d94ce/218a47331c3d4dfa87d5eed663b32c78.png, createdBy=c9df2167769, createdName=Andrew112358, createdTime=Wed Sep 16 09:25:28 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588482, encodeId=4c7e58848271, content=请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？176****8117暂无昵称 2020-02-24 00:00:00 发表: 去年7月25投稿，9月27日一审大修两个月时间，3个审稿人。11月20修回，二审两个月，今年1月20返回意见让修改一个图注问题。2月12号正式接收。, beContent=176****8117暂无昵称 2020-02-24 00:00:00 发表: 去年7月25投稿，9月27日一审大修两个月时间，3个审稿人。11月20修回，二审两个月，今年1月20返回意见让修改一个图注问题。2月12号正式接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160126/IMG56A79212C4AA18639.jpg, createdBy=fadd1683002, createdName=shaobom.shca, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911223, encodeId=111b91122357, content=现在状态是awaiting decision，是凉的意思吗？还是说内审决定送不送外审都会有这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48aa5286894, createdName=148555c3m25(暂无昵称), createdTime=Sun Dec 27 11:54:15 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115003, encodeId=5112211500396, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤免疫 经验分享：目前很困难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=DDPP, createdTime=Fri Feb 17 00:06:36 CST 2023, time=2023-02-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=586482, encodeId=66b658648216, content=Awaiting section editor handling-Awaiting reviewer selection-Awaiting reviewer assigned-Awaiting recommendation-Awaiting decision-reject，历经一周时间，这是内审没过，那送外审是什么状态呢？这里的reviewer 一直指的是editor，这样很容易误导作者以为送外审了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJFrt3WdV0nESgrJiaELZI7Xj0uNOFjt052Thc8Aomg4thuSWnkyzaZYqIJhPLkIgWaIbswDxUW2sg/132, createdBy=608d1996208, createdName=西西131401, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226934, encodeId=54b812269342d, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：临床肿瘤免疫 经验分享：2022元旦投稿 2022年3月中旬一审结果，大修，两个reviewer和editor都感兴趣，但也提了很多很多问题 2022年5月中旬修回期限最后一个小时提交一审修回 2022年6月1号二审结果，小修，两个reviewer对response很满意，reviewer 1追加了2个小问题 2022-6-10二审修回 2022-6-18 Accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2HQN0tx7bEeQhg1dSQGicdJL7tOD7icU2u5HHfxxM4Gea1zc6m7bNniaS2zETp3dS2P6cAr9Ca5Q2debcyjum1fjQ/132, createdBy=5b491679614, createdName=石头3, createdTime=Fri Jun 17 00:02:33 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971736, encodeId=64ab9e17367e, content=非常慢，而且感觉杂志很不负责任。快两个月了，状态一直都是“Awaiting Reviewer Selection”，发了两次邮件去询问，也没有回复的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4f931674603, createdName=hhhhhhq, createdTime=Tue Jun 08 09:36:33 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970704, encodeId=184d9e070419, content=审稿速度:6.0 | 投稿命中率:25.0 | 审稿费用:2500.0 偏重的研究方向：机制 经验分享：很墨迹的一个杂志，投了稿子就石沉大海，性价比不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8be71979633, createdName=laowan, createdTime=Thu Jun 03 22:40:44 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142895, encodeId=efe42142895b8, content=为什么一直保持10分以上，还是中科院二区，还不如BMC medicine吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=18525506506, createdName=ms4000001058776765, createdTime=Thu Jun 15 09:34:20 CST 2023, time=2023-06-15, status=1, ipAttribution=北京)]

2023-02-17 DDPP 来自广东省

审稿速度:2.0 | 投稿命中率:5.0
偏重的研究方向：肿瘤免疫
经验分享：目前很困难了

0 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1065742, encodeId=9dda1065e429f, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2600.0 偏重的研究方向：肿瘤免疫 经验分享：投稿两周，转态由 Awaiting reviewer selection 到Awaiting reviewer assignment 一周，10天左右变成Awaiting Recommendation，这是送外审还是没送哇，，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0985683001, createdName=ms3000001376117297, createdTime=Mon Nov 01 11:12:57 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885694, encodeId=bda8885694d0, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2600.0 偏重的研究方向：肿瘤学;免疫学 经验分享：2019.12.11投稿 2020.2.19 一审大修（但审稿人意见很好） ddl 2020.4.30 因为疫情申请延期至2020.8.30 2020.7.30 提交修改 2020.8.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/f1f34ee4cda0400b868a6737dc7d94ce/218a47331c3d4dfa87d5eed663b32c78.png, createdBy=c9df2167769, createdName=Andrew112358, createdTime=Wed Sep 16 09:25:28 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588482, encodeId=4c7e58848271, content=请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？176****8117暂无昵称 2020-02-24 00:00:00 发表: 去年7月25投稿，9月27日一审大修两个月时间，3个审稿人。11月20修回，二审两个月，今年1月20返回意见让修改一个图注问题。2月12号正式接收。, beContent=176****8117暂无昵称 2020-02-24 00:00:00 发表: 去年7月25投稿，9月27日一审大修两个月时间，3个审稿人。11月20修回，二审两个月，今年1月20返回意见让修改一个图注问题。2月12号正式接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160126/IMG56A79212C4AA18639.jpg, createdBy=fadd1683002, createdName=shaobom.shca, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911223, encodeId=111b91122357, content=现在状态是awaiting decision，是凉的意思吗？还是说内审决定送不送外审都会有这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48aa5286894, createdName=148555c3m25(暂无昵称), createdTime=Sun Dec 27 11:54:15 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115003, encodeId=5112211500396, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤免疫 经验分享：目前很困难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=DDPP, createdTime=Fri Feb 17 00:06:36 CST 2023, time=2023-02-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=586482, encodeId=66b658648216, content=Awaiting section editor handling-Awaiting reviewer selection-Awaiting reviewer assigned-Awaiting recommendation-Awaiting decision-reject，历经一周时间，这是内审没过，那送外审是什么状态呢？这里的reviewer 一直指的是editor，这样很容易误导作者以为送外审了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJFrt3WdV0nESgrJiaELZI7Xj0uNOFjt052Thc8Aomg4thuSWnkyzaZYqIJhPLkIgWaIbswDxUW2sg/132, createdBy=608d1996208, createdName=西西131401, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226934, encodeId=54b812269342d, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：临床肿瘤免疫 经验分享：2022元旦投稿 2022年3月中旬一审结果，大修，两个reviewer和editor都感兴趣，但也提了很多很多问题 2022年5月中旬修回期限最后一个小时提交一审修回 2022年6月1号二审结果，小修，两个reviewer对response很满意，reviewer 1追加了2个小问题 2022-6-10二审修回 2022-6-18 Accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2HQN0tx7bEeQhg1dSQGicdJL7tOD7icU2u5HHfxxM4Gea1zc6m7bNniaS2zETp3dS2P6cAr9Ca5Q2debcyjum1fjQ/132, createdBy=5b491679614, createdName=石头3, createdTime=Fri Jun 17 00:02:33 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971736, encodeId=64ab9e17367e, content=非常慢，而且感觉杂志很不负责任。快两个月了，状态一直都是“Awaiting Reviewer Selection”，发了两次邮件去询问，也没有回复的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4f931674603, createdName=hhhhhhq, createdTime=Tue Jun 08 09:36:33 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970704, encodeId=184d9e070419, content=审稿速度:6.0 | 投稿命中率:25.0 | 审稿费用:2500.0 偏重的研究方向：机制 经验分享：很墨迹的一个杂志，投了稿子就石沉大海，性价比不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8be71979633, createdName=laowan, createdTime=Thu Jun 03 22:40:44 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142895, encodeId=efe42142895b8, content=为什么一直保持10分以上，还是中科院二区，还不如BMC medicine吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=18525506506, createdName=ms4000001058776765, createdTime=Thu Jun 15 09:34:20 CST 2023, time=2023-06-15, status=1, ipAttribution=北京)]

2020-03-12 西西131401

Awaiting section editor handling-Awaiting reviewer selection-Awaiting reviewer assigned-Awaiting recommendation-Awaiting decision-reject，历经一周时间，这是内审没过，那送外审是什么状态呢？这里的reviewer 一直指的是editor，这样很容易误导作者以为送外审了啊

189 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1065742, encodeId=9dda1065e429f, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2600.0 偏重的研究方向：肿瘤免疫 经验分享：投稿两周，转态由 Awaiting reviewer selection 到Awaiting reviewer assignment 一周，10天左右变成Awaiting Recommendation，这是送外审还是没送哇，，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0985683001, createdName=ms3000001376117297, createdTime=Mon Nov 01 11:12:57 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885694, encodeId=bda8885694d0, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2600.0 偏重的研究方向：肿瘤学;免疫学 经验分享：2019.12.11投稿 2020.2.19 一审大修（但审稿人意见很好） ddl 2020.4.30 因为疫情申请延期至2020.8.30 2020.7.30 提交修改 2020.8.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/f1f34ee4cda0400b868a6737dc7d94ce/218a47331c3d4dfa87d5eed663b32c78.png, createdBy=c9df2167769, createdName=Andrew112358, createdTime=Wed Sep 16 09:25:28 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588482, encodeId=4c7e58848271, content=请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？176****8117暂无昵称 2020-02-24 00:00:00 发表: 去年7月25投稿，9月27日一审大修两个月时间，3个审稿人。11月20修回，二审两个月，今年1月20返回意见让修改一个图注问题。2月12号正式接收。, beContent=176****8117暂无昵称 2020-02-24 00:00:00 发表: 去年7月25投稿，9月27日一审大修两个月时间，3个审稿人。11月20修回，二审两个月，今年1月20返回意见让修改一个图注问题。2月12号正式接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160126/IMG56A79212C4AA18639.jpg, createdBy=fadd1683002, createdName=shaobom.shca, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911223, encodeId=111b91122357, content=现在状态是awaiting decision，是凉的意思吗？还是说内审决定送不送外审都会有这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48aa5286894, createdName=148555c3m25(暂无昵称), createdTime=Sun Dec 27 11:54:15 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115003, encodeId=5112211500396, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤免疫 经验分享：目前很困难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=DDPP, createdTime=Fri Feb 17 00:06:36 CST 2023, time=2023-02-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=586482, encodeId=66b658648216, content=Awaiting section editor handling-Awaiting reviewer selection-Awaiting reviewer assigned-Awaiting recommendation-Awaiting decision-reject，历经一周时间，这是内审没过，那送外审是什么状态呢？这里的reviewer 一直指的是editor，这样很容易误导作者以为送外审了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJFrt3WdV0nESgrJiaELZI7Xj0uNOFjt052Thc8Aomg4thuSWnkyzaZYqIJhPLkIgWaIbswDxUW2sg/132, createdBy=608d1996208, createdName=西西131401, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226934, encodeId=54b812269342d, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：临床肿瘤免疫 经验分享：2022元旦投稿 2022年3月中旬一审结果，大修，两个reviewer和editor都感兴趣，但也提了很多很多问题 2022年5月中旬修回期限最后一个小时提交一审修回 2022年6月1号二审结果，小修，两个reviewer对response很满意，reviewer 1追加了2个小问题 2022-6-10二审修回 2022-6-18 Accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2HQN0tx7bEeQhg1dSQGicdJL7tOD7icU2u5HHfxxM4Gea1zc6m7bNniaS2zETp3dS2P6cAr9Ca5Q2debcyjum1fjQ/132, createdBy=5b491679614, createdName=石头3, createdTime=Fri Jun 17 00:02:33 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971736, encodeId=64ab9e17367e, content=非常慢，而且感觉杂志很不负责任。快两个月了，状态一直都是“Awaiting Reviewer Selection”，发了两次邮件去询问，也没有回复的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4f931674603, createdName=hhhhhhq, createdTime=Tue Jun 08 09:36:33 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970704, encodeId=184d9e070419, content=审稿速度:6.0 | 投稿命中率:25.0 | 审稿费用:2500.0 偏重的研究方向：机制 经验分享：很墨迹的一个杂志，投了稿子就石沉大海，性价比不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8be71979633, createdName=laowan, createdTime=Thu Jun 03 22:40:44 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142895, encodeId=efe42142895b8, content=为什么一直保持10分以上，还是中科院二区，还不如BMC medicine吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=18525506506, createdName=ms4000001058776765, createdTime=Thu Jun 15 09:34:20 CST 2023, time=2023-06-15, status=1, ipAttribution=北京)]

2022-06-17 石头3

审稿速度:3.0 | 投稿命中率:5.0
偏重的研究方向：临床肿瘤免疫
经验分享：2022元旦投稿
2022年3月中旬一审结果，大修，两个reviewer和editor都感兴趣，但也提了很多很多问题
2022年5月中旬修回期限最后一个小时提交一审修回
2022年6月1号二审结果，小修，两个reviewer对response很满意，reviewer 1追加了2个小问题
2022-6-10二审修回
2022-6-18 Accept！

86 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1065742, encodeId=9dda1065e429f, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2600.0 偏重的研究方向：肿瘤免疫 经验分享：投稿两周，转态由 Awaiting reviewer selection 到Awaiting reviewer assignment 一周，10天左右变成Awaiting Recommendation，这是送外审还是没送哇，，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0985683001, createdName=ms3000001376117297, createdTime=Mon Nov 01 11:12:57 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885694, encodeId=bda8885694d0, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2600.0 偏重的研究方向：肿瘤学;免疫学 经验分享：2019.12.11投稿 2020.2.19 一审大修（但审稿人意见很好） ddl 2020.4.30 因为疫情申请延期至2020.8.30 2020.7.30 提交修改 2020.8.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/f1f34ee4cda0400b868a6737dc7d94ce/218a47331c3d4dfa87d5eed663b32c78.png, createdBy=c9df2167769, createdName=Andrew112358, createdTime=Wed Sep 16 09:25:28 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588482, encodeId=4c7e58848271, content=请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？176****8117暂无昵称 2020-02-24 00:00:00 发表: 去年7月25投稿，9月27日一审大修两个月时间，3个审稿人。11月20修回，二审两个月，今年1月20返回意见让修改一个图注问题。2月12号正式接收。, beContent=176****8117暂无昵称 2020-02-24 00:00:00 发表: 去年7月25投稿，9月27日一审大修两个月时间，3个审稿人。11月20修回，二审两个月，今年1月20返回意见让修改一个图注问题。2月12号正式接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160126/IMG56A79212C4AA18639.jpg, createdBy=fadd1683002, createdName=shaobom.shca, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911223, encodeId=111b91122357, content=现在状态是awaiting decision，是凉的意思吗？还是说内审决定送不送外审都会有这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48aa5286894, createdName=148555c3m25(暂无昵称), createdTime=Sun Dec 27 11:54:15 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115003, encodeId=5112211500396, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤免疫 经验分享：目前很困难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=DDPP, createdTime=Fri Feb 17 00:06:36 CST 2023, time=2023-02-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=586482, encodeId=66b658648216, content=Awaiting section editor handling-Awaiting reviewer selection-Awaiting reviewer assigned-Awaiting recommendation-Awaiting decision-reject，历经一周时间，这是内审没过，那送外审是什么状态呢？这里的reviewer 一直指的是editor，这样很容易误导作者以为送外审了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJFrt3WdV0nESgrJiaELZI7Xj0uNOFjt052Thc8Aomg4thuSWnkyzaZYqIJhPLkIgWaIbswDxUW2sg/132, createdBy=608d1996208, createdName=西西131401, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226934, encodeId=54b812269342d, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：临床肿瘤免疫 经验分享：2022元旦投稿 2022年3月中旬一审结果，大修，两个reviewer和editor都感兴趣，但也提了很多很多问题 2022年5月中旬修回期限最后一个小时提交一审修回 2022年6月1号二审结果，小修，两个reviewer对response很满意，reviewer 1追加了2个小问题 2022-6-10二审修回 2022-6-18 Accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2HQN0tx7bEeQhg1dSQGicdJL7tOD7icU2u5HHfxxM4Gea1zc6m7bNniaS2zETp3dS2P6cAr9Ca5Q2debcyjum1fjQ/132, createdBy=5b491679614, createdName=石头3, createdTime=Fri Jun 17 00:02:33 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971736, encodeId=64ab9e17367e, content=非常慢，而且感觉杂志很不负责任。快两个月了，状态一直都是“Awaiting Reviewer Selection”，发了两次邮件去询问，也没有回复的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4f931674603, createdName=hhhhhhq, createdTime=Tue Jun 08 09:36:33 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970704, encodeId=184d9e070419, content=审稿速度:6.0 | 投稿命中率:25.0 | 审稿费用:2500.0 偏重的研究方向：机制 经验分享：很墨迹的一个杂志，投了稿子就石沉大海，性价比不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8be71979633, createdName=laowan, createdTime=Thu Jun 03 22:40:44 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142895, encodeId=efe42142895b8, content=为什么一直保持10分以上，还是中科院二区，还不如BMC medicine吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=18525506506, createdName=ms4000001058776765, createdTime=Thu Jun 15 09:34:20 CST 2023, time=2023-06-15, status=1, ipAttribution=北京)]

2021-06-08 hhhhhhq

非常慢，而且感觉杂志很不负责任。快两个月了，状态一直都是“Awaiting Reviewer Selection”，发了两次邮件去询问，也没有回复的。

69 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1065742, encodeId=9dda1065e429f, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2600.0 偏重的研究方向：肿瘤免疫 经验分享：投稿两周，转态由 Awaiting reviewer selection 到Awaiting reviewer assignment 一周，10天左右变成Awaiting Recommendation，这是送外审还是没送哇，，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0985683001, createdName=ms3000001376117297, createdTime=Mon Nov 01 11:12:57 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885694, encodeId=bda8885694d0, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2600.0 偏重的研究方向：肿瘤学;免疫学 经验分享：2019.12.11投稿 2020.2.19 一审大修（但审稿人意见很好） ddl 2020.4.30 因为疫情申请延期至2020.8.30 2020.7.30 提交修改 2020.8.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/f1f34ee4cda0400b868a6737dc7d94ce/218a47331c3d4dfa87d5eed663b32c78.png, createdBy=c9df2167769, createdName=Andrew112358, createdTime=Wed Sep 16 09:25:28 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588482, encodeId=4c7e58848271, content=请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？176****8117暂无昵称 2020-02-24 00:00:00 发表: 去年7月25投稿，9月27日一审大修两个月时间，3个审稿人。11月20修回，二审两个月，今年1月20返回意见让修改一个图注问题。2月12号正式接收。, beContent=176****8117暂无昵称 2020-02-24 00:00:00 发表: 去年7月25投稿，9月27日一审大修两个月时间，3个审稿人。11月20修回，二审两个月，今年1月20返回意见让修改一个图注问题。2月12号正式接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160126/IMG56A79212C4AA18639.jpg, createdBy=fadd1683002, createdName=shaobom.shca, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911223, encodeId=111b91122357, content=现在状态是awaiting decision，是凉的意思吗？还是说内审决定送不送外审都会有这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48aa5286894, createdName=148555c3m25(暂无昵称), createdTime=Sun Dec 27 11:54:15 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115003, encodeId=5112211500396, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤免疫 经验分享：目前很困难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=DDPP, createdTime=Fri Feb 17 00:06:36 CST 2023, time=2023-02-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=586482, encodeId=66b658648216, content=Awaiting section editor handling-Awaiting reviewer selection-Awaiting reviewer assigned-Awaiting recommendation-Awaiting decision-reject，历经一周时间，这是内审没过，那送外审是什么状态呢？这里的reviewer 一直指的是editor，这样很容易误导作者以为送外审了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJFrt3WdV0nESgrJiaELZI7Xj0uNOFjt052Thc8Aomg4thuSWnkyzaZYqIJhPLkIgWaIbswDxUW2sg/132, createdBy=608d1996208, createdName=西西131401, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226934, encodeId=54b812269342d, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：临床肿瘤免疫 经验分享：2022元旦投稿 2022年3月中旬一审结果，大修，两个reviewer和editor都感兴趣，但也提了很多很多问题 2022年5月中旬修回期限最后一个小时提交一审修回 2022年6月1号二审结果，小修，两个reviewer对response很满意，reviewer 1追加了2个小问题 2022-6-10二审修回 2022-6-18 Accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2HQN0tx7bEeQhg1dSQGicdJL7tOD7icU2u5HHfxxM4Gea1zc6m7bNniaS2zETp3dS2P6cAr9Ca5Q2debcyjum1fjQ/132, createdBy=5b491679614, createdName=石头3, createdTime=Fri Jun 17 00:02:33 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971736, encodeId=64ab9e17367e, content=非常慢，而且感觉杂志很不负责任。快两个月了，状态一直都是“Awaiting Reviewer Selection”，发了两次邮件去询问，也没有回复的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4f931674603, createdName=hhhhhhq, createdTime=Tue Jun 08 09:36:33 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970704, encodeId=184d9e070419, content=审稿速度:6.0 | 投稿命中率:25.0 | 审稿费用:2500.0 偏重的研究方向：机制 经验分享：很墨迹的一个杂志，投了稿子就石沉大海，性价比不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8be71979633, createdName=laowan, createdTime=Thu Jun 03 22:40:44 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142895, encodeId=efe42142895b8, content=为什么一直保持10分以上，还是中科院二区，还不如BMC medicine吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=18525506506, createdName=ms4000001058776765, createdTime=Thu Jun 15 09:34:20 CST 2023, time=2023-06-15, status=1, ipAttribution=北京)]

2021-06-03 laowan

审稿速度:6.0 | 投稿命中率:25.0 | 审稿费用:2500.0
偏重的研究方向：机制
经验分享：很墨迹的一个杂志，投了稿子就石沉大海，性价比不高。

62 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1065742, encodeId=9dda1065e429f, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2600.0 偏重的研究方向：肿瘤免疫 经验分享：投稿两周，转态由 Awaiting reviewer selection 到Awaiting reviewer assignment 一周，10天左右变成Awaiting Recommendation，这是送外审还是没送哇，，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0985683001, createdName=ms3000001376117297, createdTime=Mon Nov 01 11:12:57 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885694, encodeId=bda8885694d0, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:2600.0 偏重的研究方向：肿瘤学;免疫学 经验分享：2019.12.11投稿 2020.2.19 一审大修（但审稿人意见很好） ddl 2020.4.30 因为疫情申请延期至2020.8.30 2020.7.30 提交修改 2020.8.23 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/f1f34ee4cda0400b868a6737dc7d94ce/218a47331c3d4dfa87d5eed663b32c78.png, createdBy=c9df2167769, createdName=Andrew112358, createdTime=Wed Sep 16 09:25:28 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588482, encodeId=4c7e58848271, content=请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？176****8117暂无昵称 2020-02-24 00:00:00 发表: 去年7月25投稿，9月27日一审大修两个月时间，3个审稿人。11月20修回，二审两个月，今年1月20返回意见让修改一个图注问题。2月12号正式接收。, beContent=176****8117暂无昵称 2020-02-24 00:00:00 发表: 去年7月25投稿，9月27日一审大修两个月时间，3个审稿人。11月20修回，二审两个月，今年1月20返回意见让修改一个图注问题。2月12号正式接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160126/IMG56A79212C4AA18639.jpg, createdBy=fadd1683002, createdName=shaobom.shca, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911223, encodeId=111b91122357, content=现在状态是awaiting decision，是凉的意思吗？还是说内审决定送不送外审都会有这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48aa5286894, createdName=148555c3m25(暂无昵称), createdTime=Sun Dec 27 11:54:15 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115003, encodeId=5112211500396, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤免疫 经验分享：目前很困难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=DDPP, createdTime=Fri Feb 17 00:06:36 CST 2023, time=2023-02-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=586482, encodeId=66b658648216, content=Awaiting section editor handling-Awaiting reviewer selection-Awaiting reviewer assigned-Awaiting recommendation-Awaiting decision-reject，历经一周时间，这是内审没过，那送外审是什么状态呢？这里的reviewer 一直指的是editor，这样很容易误导作者以为送外审了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJFrt3WdV0nESgrJiaELZI7Xj0uNOFjt052Thc8Aomg4thuSWnkyzaZYqIJhPLkIgWaIbswDxUW2sg/132, createdBy=608d1996208, createdName=西西131401, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226934, encodeId=54b812269342d, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：临床肿瘤免疫 经验分享：2022元旦投稿 2022年3月中旬一审结果，大修，两个reviewer和editor都感兴趣，但也提了很多很多问题 2022年5月中旬修回期限最后一个小时提交一审修回 2022年6月1号二审结果，小修，两个reviewer对response很满意，reviewer 1追加了2个小问题 2022-6-10二审修回 2022-6-18 Accept！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2HQN0tx7bEeQhg1dSQGicdJL7tOD7icU2u5HHfxxM4Gea1zc6m7bNniaS2zETp3dS2P6cAr9Ca5Q2debcyjum1fjQ/132, createdBy=5b491679614, createdName=石头3, createdTime=Fri Jun 17 00:02:33 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971736, encodeId=64ab9e17367e, content=非常慢，而且感觉杂志很不负责任。快两个月了，状态一直都是“Awaiting Reviewer Selection”，发了两次邮件去询问，也没有回复的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4f931674603, createdName=hhhhhhq, createdTime=Tue Jun 08 09:36:33 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970704, encodeId=184d9e070419, content=审稿速度:6.0 | 投稿命中率:25.0 | 审稿费用:2500.0 偏重的研究方向：机制 经验分享：很墨迹的一个杂志，投了稿子就石沉大海，性价比不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8be71979633, createdName=laowan, createdTime=Thu Jun 03 22:40:44 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142895, encodeId=efe42142895b8, content=为什么一直保持10分以上，还是中科院二区，还不如BMC medicine吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=18525506506, createdName=ms4000001058776765, createdTime=Thu Jun 15 09:34:20 CST 2023, time=2023-06-15, status=1, ipAttribution=北京)]

2023-06-15 ms4000001058776765 来自北京

为什么一直保持10分以上，还是中科院二区，还不如BMC medicine吗？

37 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务